Science & Innovation Forum - Emerging Therapies for Sickle Cell Disease - AABB/QuidelOrtho
Exploring Emerging Therapies for Sickle Cell Disease: A Deep Dive
In the continuous pursuit of advancing healthcare, a crossroads of scientific innovation and compassionate patient care is revealed. Sickle Cell Disease (SCD) remains a significant challenge, affecting millions of lives worldwide. As National Sickle Cell Awareness Month is commemorated, you are invited to delve into cutting-edge therapies in the realm of Sickle Cell Disease on Friday, September 22, 2023, from 2:00 – 3:00 PM (ET). This Science & Innovation Forum, presented by QuidelOrtho and moderated by Jeff Wren, Vice President, Biotherapies, AABB, promises to be an enlightening journey into the evolving landscape of SCD research.
Unveiling Dr. Titilope Fasipe’s Insights
At the heart of this transformative event is Dr. Titilope Fasipe, MD, PhD, the Co-Director of the Sickle Cell & Thalassemia Program at Texas Children’s Cancer & Hematology Center and an Assistant Professor in the Department of Pediatrics at Baylor College of Medicine/Texas Children’s Hospital. Dr. Fasipe is not only a distinguished medical professional but also a Sickle Cell Warrior. Her personal experiences offer a unique perspective that goes beyond the confines of clinical knowledge.
The Challenges in Treating Sickle Cell Disease
Dr. Fasipe will take you deep into the challenges faced in treating Sickle Cell Disease patients. This isn’t just another medical discussion; it’s a heartfelt exploration of the trials and tribulations that individuals with SCD endure daily. By gaining insights into these challenges, a better appreciation of the urgency of advancing SCD therapies can be achieved.
Promising Gene and Cellular Treatments
One of the most riveting aspects of this forum is the exploration of emerging SCD therapies. Dr. Fasipe will shed light on groundbreaking treatments, including gene and cellular therapies, that hold promise for transforming the lives of those with SCD. These therapies represent a ray of hope for patients and their families.
The journey through this Science & Innovation Forum will yield invaluable insights:
1. Current and Emerging Treatments for Sickle Cell Disease (SCD)
Delve into the present landscape of SCD treatments, understanding what is available to patients today, and what lies on the horizon. This insight is crucial for healthcare professionals and patients alike.
2. The Outlook for Introducing New SCD Therapies to the Market
The pharmaceutical and biotechnology industry is evolving rapidly. Dr. Fasipe will provide her expert opinion on the potential for new SCD therapies to reach the market and benefit patients.
3. Advocating for SCD Patients within the Healthcare Environment
Advocacy is a powerful tool for change. Learn how to be a voice for SCD patients, ensuring that their needs are met within the complex healthcare landscape.
This Science & Innovation Forum is open to everyone and comes at no cost, but registration is mandatory. By registering for this program hosted by AABB, participants agree to share their information with the program sponsor, QuidelOrtho. Upon registration, an automated email will be received from firstname.lastname@example.org containing unique access instructions. Please check spam or junk email folders if the email is not received, and add email@example.com to the safe sender list. The program will be conducted on GoToWebinar, so performing a System Check for GoToWebinar before the live program is recommended.
Meet the Distinguished Faculty
- Moderator: Jeff Wren, Vice President, Biotherapies, AABB
- Speaker: Dr. Titilope Fasipe, MD, PhD, Co-Director, Sickle Cell & Thalassemia Program, Texas Children’s Cancer & Hematology Center; Assistant Professor, Department of Pediatrics, Baylor College of Medicine/Texas Children’s Hospital
Please note that the content of this event was developed independently from the AABB continuing education program. The opinions expressed are those of the faculty. Continuing education credit is not available.
Science & Innovation Forums are live and on-demand programs presented by companies serving the AABB community. These programs address critical needs in the field, which can be addressed by the sponsor’s technological solutions. Registration is complimentary for all participants.
Don’t miss this opportunity to be part of a transformative discussion that could shape the future of Sickle Cell Disease treatment. Join on September 22, 2023, and together, let’s make a difference.